|Anatomy of the Prostate|
|Copyright © Nucleus Medical Media, Inc.|
Reasons for Test
- Monitor treatment effectiveness for prostate cancer
- Help determine if cancer has returned in men who have already been treated for prostate cancer
- Test for other conditions, like prostatitis , or benign prostatic hyperplasia
What to Expect
Prior to Test
- Ejaculation can cause PSA levels to rise. Avoid sexual activity for 24 hours before testing.
- Some procedures can elevate PSA levels. Schedule your PSA test several weeks after any of these:
- Wait several weeks after successful treatment of prostate infections.
- Some medications can lower PSA levels. Talk to your doctor about any medications, herbs, or supplements you take.
Description of Test
How Long Will It Take?
Will It Hurt?
Call Your Doctor
- Bleeding from the puncture site
- Red, swollen, or painful puncture site
- If you have not heard from your doctor in 1-2 weeks
American Cancer Society http://www.cancer.org
Urology Care Foundation http://www.urologyhealth.org
Canadian Cancer Society http://www.cancer.ca
Prostate Cancer Canada http://www.prostatecancer.ca
Fang J, Metter EJ, et al. PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/mL. Urology. 2002;59:889-893.
How did the USPSTF arrive at this recommendation? US Preventative Services Task Force website. Available at: http://www.uspreventiveservicestaskforce.org/Page/SupportingDoc/prostate-cancer-screening/how-did-the-uspstf-arrive-at-this-recommendation-. Accessed April 17, 2013.
PSA testing for the pretreatment staging and posttreatment management of prostate cancer: 2013 revision of 2009 best practice statement. American Urological Association website. Available at: http://www.auanet.org/education/guidelines/prostate-specific-antigen.cfm. Accessed April 17, 2013.
Prostate cancer screening. EBSCO DynaMed website. http://www.ebscohost.com/dynamed. Updated March 15, 2013. Accessed April 17, 2013.
Prostate-specific antigen (PSA) Test. National Cancer Institute website. Available at: http://www.cancer.gov/cancertopics/factsheet/Detection/PSA. Updated July 24, 2012. Accessed April 17, 2013.
Screening for prostate cancer: current recommendation. US Preventative Services Task Force website. Available at: http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatecancerfaq.htm. Accessed April 17, 2013.
Stephan C, Stroebel G, et al. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL. Cancer. 2005;104:993-1003.
5/6/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Schröder FH, Hugosson J, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-1328.
- Reviewer: Adrienne Carmack, MD
- Review Date: 01/2015 -
- Update Date: 04/29/2014 -